Inappropriate polypharmacy – the excessive or unnecessary use of multiple medications – is a major driver of emergency hospital admissions among adults aged 65 and…
Read more...The Scottish Medicines Consortium (SMC) has rejected a new Alzheimer’s drug, lecanemab (sold under the brand name Leqembi), for use on the NHS in Scotland….
Read more...The ALBORADA Trust, based near Newmarket, has donated £5 million to Alzheimer’s Research UK. The donation supports the ALBORADA Drug Discovery Institute (DDI) at the…
Read more...The Food and Drug Administration has approved lecanemab, a new drug for Alzheimer’s disease, for use across the US. It’s been less than two years…
Read more...A new tool has been developed to assess the likelihood of an older adult who is discharged from hospital suffering from medication-related harm (MRH). Specifically…
Read more...A drug normally used to treat enlarged prostate may also be able to slow the progress of Parkinson’s disease, scientists have said. Terazosin could reduce…
Read more...Sign up to receive the latest issues, along with highlights of the latest sector news and more from The Carer, delivered directly to your inbox twice a week!
